Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000281568 | SCV000339947 | uncertain significance | not provided | 2016-03-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000807309 | SCV000947356 | pathogenic | Deficiency of isobutyryl-CoA dehydrogenase | 2023-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 156 of the ACAD8 protein (p.Ala156Ser). This variant is present in population databases (rs201273972, gnomAD 0.1%). This missense change has been observed in individual(s) with clinical features of isobutyryl-CoA dehydrogenase deficiency (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 286498). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACAD8 protein function. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000807309 | SCV001529510 | uncertain significance | Deficiency of isobutyryl-CoA dehydrogenase | 2018-11-19 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |